Teneliximab

Tax included
Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion.
MedChemExpress 
HY-P99321

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
COVID-19-anti-virus
CAS
299423-37-3